Key Points
–
On Dec. 8, 2025, the Executive Vice President and Chief Commercial Officer of Collegium Pharmaceutical sold 17,600 shares directly through an exercise of options.
–
The sale represented 14.5% of Dreyer's direct holdings at the time, reducing his direct ownership to 103,613…